Affiliation:
1. School of Medicine, Zhejiang University City College, 51 Hu-Zhou Street, Hangzhou 310015, China
2. Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
Abstract
The emergency of responsive drug delivery systems has contributed to reduced cytotoxicity,
improved permeability in tissues and extended circulation time of the active drug. In particular,
enzyme-responsive nanoplatforms have attracted a lot of attention due to the specificity and
efficiency of an enzyme-catalyzed reaction. In this review, enzyme-based mono responsive drug delivery
systems designed in the past 5 years have been summarized. These drug delivery systems
were introduced by different tumor-related enzymes such as matrix metalloproteinase, esterase,
hyaluronidase, caspase and cathepsin. Moreover, the enzyme-sensitive nanoplatforms activated by
dual-stimuli have been also described. Although great progress had been made in the past years,
the translation into clinical practice is still difficult. Thus, three obstacles (enzyme heterogeneity, reaction
environment, animal model) were also discussed. In short, enzyme-activated drug delivery
systems offer great potential in treating cancers.
Funder
National Key Research and Development project intergovernmental cooperation in science and technology of China
Publisher
Bentham Science Publishers Ltd.
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献